Adipocytes Modulate the Phenotype of Human Macrophages through Secreted Lipids

Previous studies have shown accumulation and an enhanced proinflammatory profile of macrophages in adipose tissue of obese mice, indicating the presence of an interaction between adipocytes and macrophages in this tissue. However, the consequences of this interaction in humans are yet incompletely understood. In this study, we explored the modulating effects of adipocytes on the phenotype of macrophages in humans and studied the possible molecular pathways involved. Adipocyte-conditioned media (ACM) treatment of macrophages for 48 h strongly reduced the LPS-induced IL-12p40 secretion by macrophages, whereas the production of TNF-α and other cytokines remained largely unaffected. This effect was independent of the source of adipocytes. Interestingly, the level of inhibition correlated directly with body mass index (BMI) of the adipocyte donor. Because adipocytes release many different cytokines, adipokines, and lipids, we have separated the protein and lipid fractions of ACM, to obtain insight into the molecular nature of the soluble mediators underlying the observed effect. These experiments revealed that the inhibitory effect resided predominantly in the lipid fraction. Further studies revealed that PGE2 and linoleic and oleic acid were potent inhibitors of IL-12p40 secretion. Interestingly, concentrations of these ACM-derived lipids increased with increase in BMI of the adipocyte donor, suggesting that they could mediate the BMI-dependent effects of ACM. To our knowledge, these results provide first evidence that obesity-related changes in adipose tissue macrophage phenotype could be mediated by adipocyte-derived lipids in humans. Intriguingly, these changes appear to be different from those in murine obesity.

[1]  M. Giera,et al.  Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. , 2012, Biochimica et biophysica acta.

[2]  F. Gao,et al.  Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat , 2012, The Journal of Immunology.

[3]  C. Serhan,et al.  Metabolomics‐Lipidomics of Eicosanoids and Docosanoids Generated by Phagocytes , 2011, Current protocols in immunology.

[4]  P. Fischer-Posovszky,et al.  THP-1 Macrophages and SGBS Adipocytes – A New Human in vitro Model System of Inflamed Adipose Tissue , 2011, Front. Endocrin..

[5]  A. Bouloumié,et al.  Immune cells in adipose tissue: key players in metabolic disorders. , 2011, Diabetes & metabolism.

[6]  C. Lumeng,et al.  Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states , 2011, Current opinion in clinical nutrition and metabolic care.

[7]  Yunan Tang,et al.  Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese‐diabetic mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  P. Scherer,et al.  Adipose tissue remodeling and obesity. , 2011, The Journal of clinical investigation.

[9]  David Montaner,et al.  Differential Lipid Partitioning Between Adipocytes and Tissue Macrophages Modulates Macrophage Lipotoxicity and M2/M1 Polarization in Obese Mice , 2011, Diabetes.

[10]  R. Morita,et al.  Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance , 2011, Nature communications.

[11]  R. Toes,et al.  The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype , 2011, Annals of the rheumatic diseases.

[12]  R. Curi,et al.  Molecular Mechanisms by Which Saturated Fatty Acids Modulate TNF-α Expression in Mouse Macrophage Lineage , 2011, Cell Biochemistry and Biophysics.

[13]  K. Strissel,et al.  T‐Cell Recruitment and Th1 Polarization in Adipose Tissue During Diet‐Induced Obesity in C57BL/6 Mice , 2010, Obesity.

[14]  R. Zechner,et al.  Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. , 2010, The Journal of clinical investigation.

[15]  Liwu Li,et al.  Molecular mechanism underlying the inflammatory complication of leptin in macrophages. , 2010, Molecular immunology.

[16]  M. Al-Omran,et al.  Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. , 2010, American journal of physiology. Heart and circulatory physiology.

[17]  Emily K Anderson,et al.  Adipose tissue recruitment of leukocytes , 2010, Current opinion in lipidology.

[18]  G. Smyth,et al.  Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human Obesity , 2010, Diabetes.

[19]  K. Walsh,et al.  Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype* , 2009, The Journal of Biological Chemistry.

[20]  T. Kadowaki,et al.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity , 2009, Nature Medicine.

[21]  A. Lichtenstein,et al.  In vitro fatty acid enrichment of macrophages alters inflammatory response and net cholesterol accumulation , 2009, British Journal of Nutrition.

[22]  O. Wiklund,et al.  Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. , 2009, Atherosclerosis.

[23]  M. Wachtel,et al.  Adipose Tissue: The New Endocrine Organ? A Review Article , 2009, Digestive Diseases and Sciences.

[24]  A. Saltiel,et al.  Phenotypic Switching of Adipose Tissue Macrophages With Obesity Is Generated by Spatiotemporal Differences in Macrophage Subtypes , 2008, Diabetes.

[25]  S. Watkins,et al.  Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism , 2008, Cell.

[26]  A. Yoshimura,et al.  Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells. , 2008, International immunology.

[27]  Chih-Hao Lee,et al.  Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. , 2008, Cell metabolism.

[28]  M. Wegner,et al.  IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. , 2008, Cytokine.

[29]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[30]  F. Karpe,et al.  Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages , 2008, Circulation.

[31]  G. Zlabinger,et al.  Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production , 2007, International Journal of Obesity.

[32]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[33]  S. Khader,et al.  IL-12p40: an inherently agonistic cytokine. , 2007, Trends in immunology.

[34]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[35]  T. Kadowaki,et al.  Overexpression of Monocyte Chemoattractant Protein-1 in Adipose Tissues Causes Macrophage Recruitment and Insulin Resistance* , 2006, Journal of Biological Chemistry.

[36]  G. Patterson,et al.  IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. , 2006, American journal of respiratory and critical care medicine.

[37]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[38]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[39]  T. Suganami,et al.  A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[40]  M. Freudenberg,et al.  IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages. , 2005, International immunology.

[41]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[42]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[43]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[44]  M. Neurath,et al.  An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn’s disease and experimental colitis in vivo , 2004, Gut.

[45]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.

[46]  D. Loskutoff,et al.  Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[48]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[49]  N. Kajiwara,et al.  Interleukin 12 P40 Production by Barrier Epithelial Cells during Airway Inflammation , 2001, The Journal of experimental medicine.

[50]  V. Sánchez-Margalet,et al.  Human leptin stimulates proliferation and activation of human circulating monocytes. , 1999, Cellular immunology.

[51]  D. Salamon,et al.  Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus , 1998, Diabetologia.

[52]  X. Cheng,et al.  Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice. , 1997, Journal of immunology.

[53]  L. Aarden,et al.  Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production , 1995, The Journal of experimental medicine.

[54]  D. Carvajal,et al.  Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist , 1995, European journal of immunology.

[55]  M. Gately,et al.  Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. , 1995, Journal of immunology.

[56]  Giorgio,et al.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.